Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy. (Glycotreat)
Leiden University Medical Center
Clinical Trial Study
Sponsor:
Leiden University Medical Center
Collaborators:
Dutch Kidney Foundation
Health Holland
Radboud University
Subsidizing Party:
Health Holland (Dutch Top Sector Life Sciences & Health)
Laan van Nieuw Oost-Indië 334,
2593 CE Den Haag
The Netherlands
Dutch Kidney Foundation
Groot Hertoginnelaan 34
1405 EE, Bussum
The Netherlands
Laboratory Sites:
Leiden University Medical Center, The Netherlands
Radboud University Medical Center, The Netherlands
Objective:
To investigate whether intervention with the dietary supplement Endocalyx™ improves the
Microvascular Health Index between baseline and 3 months in type 2 diabetic South Asian patients with
microalbuminuria in comparison to the placebo group.
Copyright © 2019-2024 NuLife Sciences, Inc. - A BioRegenx Company. All rights reserved.
The statements (appearing on this website) have not been evaluated by the Food and Drug Administration. NuLife products are not intended to diagnose, treat, cure, or prevent any disease. If you are pregnant, nursing, on medication, have a medical condition or beginning a weight control system, consult your physician before using NuLife products. *The testimonials presented apply only to the individuals depicted, cannot be guaranteed, and should not be considered typical.